Report Detail

Medical Industry Covid-19 Impact on Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2020-2026

  • RnM3953134
  • |
  • 26 April, 2020
  • |
  • Global
  • |
  • 128 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant DNA (rDNA) Technology market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant DNA (rDNA) Technology industry.
Based on our recent survey, we have several different scenarios about the Recombinant DNA (rDNA) Technology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant DNA (rDNA) Technology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA (rDNA) Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA (rDNA) Technology market in terms of revenue.
Players, stakeholders, and other participants in the global Recombinant DNA (rDNA) Technology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each component segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Recombinant DNA (rDNA) Technology market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Recombinant DNA (rDNA) Technology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA (rDNA) Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA (rDNA) Technology market.
The following players are covered in this report:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
Recombinant DNA (rDNA) Technology Breakdown Data by Component
Expression System
Cloning Vector
Recombinant DNA (rDNA) Technology Breakdown Data by Application
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
  • 1.4 Covid-19 Implications on Market by Component
    • 1.4.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Component: 2020 VS 2026
    • 1.4.2 Expression System
    • 1.4.3 Cloning Vector
  • 1.5 Covid-19 Implications on Market by Application
    • 1.5.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2026
    • 1.5.2 Biotechnology and Pharmaceutical Companies
    • 1.5.3 Academic and Government Research Institutes
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Recombinant DNA (rDNA) Technology Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Recombinant DNA (rDNA) Technology Industry
      • 1.6.1.1 Recombinant DNA (rDNA) Technology Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Recombinant DNA (rDNA) Technology Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Recombinant DNA (rDNA) Technology Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Recombinant DNA (rDNA) Technology Growth Trends by Regions
    • 2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2015-2020)
    • 2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Recombinant DNA (rDNA) Technology Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Recombinant DNA (rDNA) Technology Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Recombinant DNA (rDNA) Technology Players by Market Size
    • 3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2015-2020)
    • 3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
    • 3.2.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2019
  • 3.3 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
  • 3.4 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
  • 3.5 Date of Enter into Recombinant DNA (rDNA) Technology Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Component (2015-2026)

  • 4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Component (2015-2020)
  • 4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Component (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)
  • 5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 6.2 Recombinant DNA (rDNA) Technology Key Players in North America (2019-2020)
  • 6.3 North America Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
  • 6.4 North America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 7.2 Recombinant DNA (rDNA) Technology Key Players in Europe (2019-2020)
  • 7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
  • 7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

8 China

  • 8.1 China Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 8.2 Recombinant DNA (rDNA) Technology Key Players in China (2019-2020)
  • 8.3 China Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
  • 8.4 China Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 9.2 Recombinant DNA (rDNA) Technology Key Players in Japan (2019-2020)
  • 9.3 Japan Recombinant DNA (rDNA) Technology Market Size by Component (2015-2020)
  • 9.4 Japan Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 10.2 Recombinant DNA (rDNA) Technology Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

11 India

  • 11.1 India Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 11.2 Recombinant DNA (rDNA) Technology Key Players in India (2019-2020)
  • 11.3 India Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
  • 11.4 India Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Recombinant DNA (rDNA) Technology Market Size (2015-2020)
  • 12.2 Recombinant DNA (rDNA) Technology Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Recombinant DNA (rDNA) Technology Market Size by Type (2015-2020)
  • 12.4 Central & South America Recombinant DNA (rDNA) Technology Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
    • 13.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
    • 13.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview and Its Total Revenue
    • 13.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
    • 13.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020))
    • 13.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
  • 13.2 Profacgen
    • 13.2.1 Profacgen Company Details
    • 13.2.2 Profacgen Business Overview and Its Total Revenue
    • 13.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
    • 13.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.2.5 Profacgen Recent Development
  • 13.3 Amgen Inc
    • 13.3.1 Amgen Inc Company Details
    • 13.3.2 Amgen Inc Business Overview and Its Total Revenue
    • 13.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
    • 13.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.3.5 Amgen Inc Recent Development
  • 13.4 Novartis AG
    • 13.4.1 Novartis AG Company Details
    • 13.4.2 Novartis AG Business Overview and Its Total Revenue
    • 13.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
    • 13.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.4.5 Novartis AG Recent Development
  • 13.5 GenScript
    • 13.5.1 GenScript Company Details
    • 13.5.2 GenScript Business Overview and Its Total Revenue
    • 13.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
    • 13.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.5.5 GenScript Recent Development
  • 13.6 Pfizer Inc
    • 13.6.1 Pfizer Inc Company Details
    • 13.6.2 Pfizer Inc Business Overview and Its Total Revenue
    • 13.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
    • 13.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.6.5 Pfizer Inc Recent Development
  • 13.7 Novo Nordisk A/S
    • 13.7.1 Novo Nordisk A/S Company Details
    • 13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue
    • 13.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
    • 13.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.7.5 Novo Nordisk A/S Recent Development
  • 13.8 Eli Lilly and Company
    • 13.8.1 Eli Lilly and Company Company Details
    • 13.8.2 Eli Lilly and Company Business Overview and Its Total Revenue
    • 13.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
    • 13.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.8.5 Eli Lilly and Company Recent Development
  • 13.9 Sanofi
    • 13.9.1 Sanofi Company Details
    • 13.9.2 Sanofi Business Overview and Its Total Revenue
    • 13.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
    • 13.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.9.5 Sanofi Recent Development
  • 13.10 Biocon
    • 13.10.1 Biocon Company Details
    • 13.10.2 Biocon Business Overview and Its Total Revenue
    • 13.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
    • 13.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 13.10.5 Biocon Recent Development
  • 13.11 GlaxoSmithKline plc
    • 10.11.1 GlaxoSmithKline plc Company Details
    • 10.11.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
    • 10.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
    • 10.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 10.11.5 GlaxoSmithKline plc Recent Development
  • 13.12 New England Biolabs.
    • 10.12.1 New England Biolabs. Company Details
    • 10.12.2 New England Biolabs. Business Overview and Its Total Revenue
    • 10.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
    • 10.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 10.12.5 New England Biolabs. Recent Development
  • 13.13 Cibus
    • 10.13.1 Cibus Company Details
    • 10.13.2 Cibus Business Overview and Its Total Revenue
    • 10.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
    • 10.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 10.13.5 Cibus Recent Development
  • 13.14 Monsanto Company
    • 10.14.1 Monsanto Company Company Details
    • 10.14.2 Monsanto Company Business Overview and Its Total Revenue
    • 10.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
    • 10.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 10.14.5 Monsanto Company Recent Development
  • 13.15 Horizon Discovery Group PLC
    • 10.15.1 Horizon Discovery Group PLC Company Details
    • 10.15.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
    • 10.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
    • 10.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2015-2020)
    • 10.15.5 Horizon Discovery Group PLC Recent Development

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Recombinant DNA (rDNA) Technology. Industry analysis & Market Report on Recombinant DNA (rDNA) Technology is a syndicated market report, published as Covid-19 Impact on Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Recombinant DNA (rDNA) Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,793.00
    5,586.00
    3,269.00
    6,538.00
    546,945.00
    1,093,890.00
    292,215.00
    584,430.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report